Agreement between a payer and a pharmaceutical, device or diagnostic manufacturer where the price level and/or revenue received is related to the future performance of the product in either a research or a real world environment. One category of managed-entry agreements, in contrast to the financial agreements.
Cf. managed entry agreements, Performance Based Health Outcome Reimbursement Schemes and Performance- Linked Reimbursement
Last update: 20 June 2023
Source: PPRI